Delivery Order SPE2DB20D1100-SPE2DB25FC3B0

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,202.51 firm fixed-price contract is for the supply of Methazolamide 25 mg tablets. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,529.68 firm fixed-price delivery order is for the supply of Methazolamide 25 mg tablets. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award is a delivery order (SPE2DB22D3004|SPE2DB25FQP48) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,289.40 firm fixed-price contract is for the supply of 4,568,161,238 units of the medication Methazolamide 50 mg tablets, with a performance period through May 7, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $4,168.92, is for the supply of 4,564,361,959 units of the pharmaceutical product Methazolamide 50 mg Tablet. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical...
This federal contract award, valued at $1,122.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Methazolamide 50 mg tablets, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a completion date of November 18, 2024. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, identified as SPE2DB24D1006 and SPE2DB25FCEAK, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,541.63 fixed-price delivery order is for the supply of 4566789400 units of Methazolamide 50 mg tablets. The contract has an ultimate completion date of December 24, 2024 and was awarded on December 23, 2024. Amerisourcebergen holds a significant $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $20,908.19, is for the delivery of 4,554,642,252 units of the prescription drug Methazolamide 50 mg tablets in quantities of 100 per bottle. The award is a Firm Fixed Price Delivery Order contract with a completion date of September 3, 2021. The contract does not have a set-aside designation, indicating it was...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Methazolamide 50 mg tablets under Delivery Order SPE2DX24F2PM9, which is part of the larger Indefinite Delivery Contract SPE2DX15D3202 with the Defense Logistics Agency (DLA) Troop Support Medical. The award has a ceiling value of $1,770.27 and an ultimate completion date of August 26, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,567,016,240 units of Methimazole 10 mg tablets. The firm-fixed-price delivery order contract, valued at $1,178.78, has an ultimate completion date of January 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNEPS, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,993.76, is for the delivery of 4567088146 METHAZOLAMIDE 50 MG TABLET 100S, a generic pharmaceutical product. This contract has a firm fixed-price pricing type and an ultimate completion date of January 30, 2025. The award is part of a larger...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC3B0
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,231.25 firm fixed-price delivery order is for the supply of 4,568,235,107 units of the medication Methazolamide 50 mg tablets. The award is not set-aside and has an ultimate completion date of May 14, 2025.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This prime contract enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 8/12/25, 12:16 PM